SCHEMBL27384340

SCHEMBL27384340

CC(C)c1cc2[nH]c(CNC(=O)N3CCCCC3)cc2cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EIF4A3 P38919 1/20 0.47
▸ MAPK1 P28482 1/20 0.41
▸ RAB9A P51151 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ EPHX2 P34913 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TRPV3 Q8NET8 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ METTL3 Q86U44 1/20 0.33
▸ METTL14 Q9HCE5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384655 0.99 EIF4A3 (0.48) EIF4A3MAPK1RAB9ANPC1EPHX2
SCHEMBL27384648 0.97 EIF4A3 (0.48) EIF4A3MAPK1RAB9ANPC1EPHX2
SCHEMBL27384342 0.88 EIF4A3 (0.42) EIF4A3MAPK1RAB9ANPC1EPHX2
SCHEMBL27384339 0.87 MAPK1 (0.42) EIF4A3MAPK1RAB9ANPC1EPHX2
SCHEMBL27384348 0.86 EIF4A3 (0.46) EIF4A3MAPK1RAB9ANPC1SMN1; SMN2
SCHEMBL27384352 0.86 EIF4A3 (0.49) EIF4A3MAPK1RAB9ANPC1SMN1; SMN2
SCHEMBL27384854 0.86 MAPK1 (0.41) MAPK1RAB9ANPC1EPHX2SMN1; SMN2
SCHEMBL27384264 0.83 MAPK1 (0.40) EIF4A3MAPK1RAB9ANPC1EPHX2
SCHEMBL27384346 0.82 EIF4A3 (0.45) EIF4A3MAPK1RAB9ANPC1SMN1; SMN2
SCHEMBL27382678 0.81 EIF4A3 (0.56) EIF4A3RAB9ANPC1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback